Irritability is a prevalent and challenging issue for many teenagers and their families.
The primary symptom is an exaggerated reaction to negative emotional cues, leading to temper outbursts and a persistently irritable mood.
While options like psychotherapy and medications can be beneficial for some, they may not be accessible or well-tolerated by everyone.
Our recent research, rooted in a double-blind, placebo-controlled clinical trial, indicates that broad-spectrum micronutrients (vitamins and minerals) can significantly alleviate severe irritability in teenagers.
Those with particularly disruptive behavior saw some of the most substantial improvements.
This presents a safe, scalable, and biologically-grounded alternative to conventional psychiatric treatments.
Urgent Need for More Effective Treatments
Irritability is often present in various psychiatric conditions, such as anxiety, depression, attention deficit/hyperactivity disorder (ADHD), and other disruptive behavior disorders.
The urgency for interventions that effectively target irritability, come with fewer side effects, and are accessible to all communities is clear.
Worrying statistics regarding mental health among youth show a global decline over the last two decades, reaching a “dangerous phase”, according to a Lancet commission.
Research consistently reveals a shortage of effective and accessible treatments for young people experiencing severe irritability, highlighting a pressing public health need.
Our findings stem from the Balancing Emotions of Adolescents with Micronutrients (BEAM) trial, which involved 132 unmedicated teenagers (aged 12 to 17) with moderate to severe irritability. Participants were randomly assigned to either receive micronutrients (four pills three times daily) or an active placebo for eight weeks, with monthly check-ins conducted online by a clinical psychologist.
The study yielded a high placebo response rate, indicating that mere participation in the trial helped many teenagers feel empowered to alter their behavior. Nevertheless, micronutrients demonstrated superior effectiveness over the placebo in critical areas such as irritability, emotional reactivity, and overall improvement.
Notably, we observed significant benefits among teenagers diagnosed with disruptive mood dysregulation disorder (DMDD), where 64 percent showed a positive response to micronutrients compared to just 12.5 percent within the placebo group. This highlights an unusually strong effect for a psychiatric intervention.
About the Authors
Julia J Rucklidge is a Professor of Psychology at the University of Canterbury.
Angela Sherwin is a PhD Candidate in Nutrition at the University of Canterbury.
Joseph Boden is a Professor of Psychology and Director of the Christchurch Health and Development Study at the University of Otago.
Roger Mulder is a Professor of Psychiatry at the University of Otago.
This article was first published by The Conversation and is republished under a Creative Commons licence. Read the original article.
Parents of teens receiving micronutrients rated their conduct and prosocial behaviors more favorably compared to those in the placebo group.
Additionally, micronutrient treatment was associated with quicker improvements in clinician-assessed irritability, parent-reported dysphoria, and teen-reported quality of life, stress, and prosocial behaviors.
Of particular note was the reduction in suicidal ideation, which about 25 percent of participants reported at the trial’s beginning. This symptom improved for both groups over time, but those taking micronutrients experienced a more significant positive change. Self-harm behaviors also decreased in both groups.
One notable side effect differed: diarrhea occurred more frequently in the micronutrient group (20.9 percent) compared to placebo (6.2 percent). However, this was often temporary and could be alleviated by consuming the supplements with food and water.
A small percentage (less than 10 percent) found it challenging to swallow the pills. Other side effects, such as occasional headaches, stomachaches, or dry mouths, were reported equally in both groups and typically subsided within the first few weeks.
Impact of Socioeconomic Background
The efficacy of treatment varied with the socioeconomic status of the participants.
Teens from lower socioeconomic backgrounds exhibited more significant benefits from micronutrient supplementation, a finding that holds clinical and public health importance.
Lower socioeconomic status typically correlates with higher nutritional deficiencies, chronic stress, reduced access to healthcare, and elevated rates of mental health issues.
Our findings suggest that micronutrients may address underlying nutritional challenges prevalent in disadvantaged groups.
This evidence indicates that publicly funded micronutrient supplementation could serve as a low-cost, scalable intervention, potentially reducing health disparities.
Many evidence-based psychosocial and pharmacological treatments necessitate resources, such as time, transportation, and specialist access, that often disadvantage low-income families.
In our trial, all interactions between the psychologist and the participants occurred online, and the micronutrients were delivered via courier nationwide, enhancing accessibility, particularly for rural populations.
Micronutrient supplementation could thus represent an intervention responsive to the specific needs of youth who are most vulnerable yet least supported by conventional care systems.
This study was developed in collaboration with Māori health providers within a traditional Māori framework, achieving a high representation of Māori participants (27 percent) and closely engaging with their families and health providers to improve mental health outcomes.
The BEAM trial provides strong evidence that a simple nutritional approach can significantly enhance symptoms like emotional reactivity, behavioral issues, and even suicidal thoughts.
These insights are valuable for parents, clinicians, educators, and policymakers looking for safe, practical interventions, particularly for youth who struggle to access existing treatments or do not respond favorably to them. The findings also carry critical equity implications, as teens from lower-income households demonstrated greater positive responses.
Overall, our findings offer a fresh perspective on the underlying causes of some psychiatric issues, often viewed through the lenses of chemical imbalances or family dynamics. They suggest that irritability may stem from nutritional and metabolic vulnerabilities, which may be effectively addressed through improved dietary quality combined with broad-spectrum micronutrient supplementation.
